Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology103
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo33
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer33
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond32
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance32
Mitochondria, OXPHOS, and Cancer Progression: A Modular View31
Lessons from 3D Reconstruction of Cancer26
Allogeneic CAR T Cell Therapy for Cancer21
Natural and Engineered Cytokines as Cancer Therapeutics21
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity17
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology16
Road Map to Defeat Pancreatic Cancer15
Engineering Cancer with Next-Generation Genome Editing Tools14
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies14
Cancer Cell Polarity and Extrusion14
An Erratic Path Toward Discovery14
Cancer Dependency Map: Past and Present14
0.078032970428467